Del. Code Ann. tit. 24, § 2523
Exemptions [Effective June 30, 2026]
Effective Jun 30, 202624 Del. Laws, c. 140, § 1; Code 1915, § 862; Code 1935, § 942; 24 Del. C. 1953, § 2521; 64 Del. Laws, c. 452, § 1; 68 Del. Laws, c. 206, § 1; 70 Del. Laws, c. 186, § 1; 75 Del. Laws, c. 161, § 9; 75 Del. Laws, c. 260, §§ 1, 2; 76 Del. Laws, c. 167, § 1; 84 Del. Laws, c. 158, § 2; 85 Del. Laws, c. 49, § 2; 85 Del. Laws, c. 97, § 1; 85 Del. Laws, c. 49, § 1;
Nothing in this chapter may be construed to prevent any of the following:
- (1) A student or graduate of an accredited school of pharmacy from receiving practical training pursuant to an internship or other approved program under the supervision of a pharmacist in this State.
- (2) A pharmacy intern, or a pharmacy student participating in an approved college of pharmacy coordinated practical experience program under the direct supervision of a licensed pharmacist, from performing the functions permitted under the rules and regulations of the Board and not inconsistent with this chapter.
- (3) A pharmacy technician or certified pharmacy technician from performing under the direct supervision of a pharmacist the delegated functions permitted under the rules and regulations of the Board and not inconsistent with this chapter.
- (4) A practitioner licensed under the laws of this State to practice within the scope of that practitioner’s license.
- (5) The selling at retail of over-the-counter products.
(6) A business not licensed as a pharmacy to sell gases that are used for medicinal purposes and which require a prescription, provided that:
- a. The business is registered with the Board.
- b. The sale is authorized by a written, electronic, or fax order or by a verbal order reduced to writing from a licensed practitioner.
- c. The record of the written, electronic, or fax order, or the verbal order reduced to writing is maintained on the premises of the business for at least 3 years.
- d. The gas product is stored and dispensed according to requirements established by the Board.
- (7) The sale of noncontrolled prescription drugs designated for veterinary use by a business not licensed as a pharmacy, provided that the business is registered with the Board and the sale is authorized by a written, electronic, or fax order or by a verbal order reduced to writing from a licensed veterinarian.
- (8) Pharmacist selection of appropriate dosage forms, concentrations, equivalent strengths or routes of administration of medications.
(9) a. A practitioner from dispensing the unused portion of practitioner-dispensed topical medication to the patient upon discharge or the conclusion of the visit if the practitioner-dispensed topical medication is labeled consistent with the requirements under § 2522 of this title and required for continuing treatment. If the practitioner-dispensed topical medication is used in an operating room or emergency department, the practitioner must counsel the patient on the proper use and administration of the drug.
- b. A practitioner who fails to comply with paragraph (9)a. of this section is subject to disciplinary sanction under this title.
- (10) [Repealed.]
(11) A manufacturer or wholesaler from providing distribution of dialysate drugs or devices necessary to perform home dialysis on patients with end-stage renal disease, provided that all of the following criteria are met:
- a. The dialysate drugs or devices are approved by the U.S. Food and Drug Administration as required by federal law.
- b. The dialysate drugs or devices are lawfully held by a manufacturer or a manufacturer’s agent that is properly registered with the Board as a manufacturer or wholesaler.
- c. The dialysate drugs or devices are held and delivered in their original, sealed label packaging from the manufacturing facility.
- d. The dialysate drugs or devices are delivered only by the manufacturer or the manufacturer’s agent and only upon receipt of a prescription from a practitioner.
e. The manufacturer or the manufacturer’s agent delivers the dialysate drugs or devices directly to 1 of the following:
- 1. A patient with end stage renal disease or the patient’s designee for the patient’s self-administration of dialysis therapy.
- 2. A health-care provider or institution for administration or delivery of the dialysis therapy to a patient with end stage renal disease.
24 Del. Laws, c. 140, § 1; Code 1915, § 862; Code 1935, § 942; 24 Del. C. 1953, § 2521; 64 Del. Laws, c. 452, § 1; 68 Del. Laws, c. 206, § 1; 70 Del. Laws, c. 186, § 1; 75 Del. Laws, c. 161, § 9; 75 Del. Laws, c. 260, §§ 1, 2; 76 Del. Laws, c. 167, § 1; 84 Del. Laws, c. 158, § 2; 85 Del. Laws, c. 49, § 2; 85 Del. Laws, c. 97, § 1; 85 Del. Laws, c. 49, § 1